PLIVA 327
Pill imprint PLIVA 327 has been identified as Hydralazine hydrochloride 25 mg.
Hydralazine is used in the treatment of high blood pressure; hypertensive emergency; heart failure and belongs to the drug class vasodilators. Risk cannot be ruled out during pregnancy.
Hydralazine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydralazine hydrochloride Images
- Imprint:
-
PLIVA 327
- Strength:
- 25 mg
- Color:
- Orange
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
microcrystalline cellulose
sodium starch glycolate type A potato
stearic acid
FD&C Yellow No. 6
- Drug Class:
- Vasodilators
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals
- National Drug Code (NDC):
- 50111-0327
Advertisement
More Hydralazine Hydrochloride resources
- Hydralazine (Wolters Kluwer)
- Hydralazine Tablets (Wolters Kluwer)
- hydralazine (Cerner Multum)
- hydralazine Oral, Injection, Intravenous (Micromedex) - Includes Dosage Information
- Hydralazine Hydrochloride (AHFS DI)
- Hydralazine (FDA)
- Hydralazine Tablets (FDA)
- Hydralazine Hydrochloride (Wolters Kluwer)
Search Again
